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Abstract: As a major site of glucose uptake following a meal, skeletal muscle has an important role in
whole-body glucose metabolism. Evidence in humans and animal models of insulin resistance and
type 2 diabetes suggests that alterations in mitochondrial characteristics accompany the development
of skeletal muscle insulin resistance. However, it is unclear whether changes in mitochondrial content,
respiratory function, or substrate oxidation are central to the development of insulin resistance or
occur in response to insulin resistance. Thus, this review will aim to evaluate the apparent conflicting
information placing mitochondria as a key organelle in the development of insulin resistance in
skeletal muscle.
Keywords: mitochondria; insulin resistance; skeletal muscle; type 2 diabetes; fatty acid oxidation;
lipid metabolites; mitochondrial content; mitochondrial function
1. Introduction
In response to increased blood glucose levels, such as after a meal, insulin is released by the β-cells
of the pancreas. Insulin then activates a number of different signalling pathways in various tissues [1],
with the primary aim of facilitating nutrient uptake and storage in tissues, particularly skeletal muscle,
liver, and adipose tissue. Skeletal muscle is responsible for approximately 80% of glucose uptake during
a hyperinsulinaemic euglycaemic clamp in healthy individuals [2]. When a normal or elevated insulin
level produces an attenuated biological response, this is defined as insulin resistance [3]. In muscle,
insulin resistance impairs glucose uptake and, together with impaired suppression of glucose output
by the liver, this results in hyperglycaemia and hyperlipidaemia—two factors responsible for many of
the co-morbidities associated with insulin resistance and type 2 diabetes (T2D).
Genetic susceptibility and lifestyle factors, such as poor diet, obesity, and physical inactivity,
are believed to be risk factors for T2D [4]. Many studies have shown that people with T2D, a family
history of T2D, obesity, and/or insulin resistance, have decreased skeletal muscle mitochondrial
respiratory function and/or content [5–9]. Humans with insulin resistance and T2D also have a
decreased expression of genes encoding key enzymes involved in fatty acid oxidation and the
tricarboxylic acid (TCA) cycle, as well as components of the respiratory chain [10]; a lower abundance
of mitochondrial proteins has also been reported [11]. In addition, some studies have reported a
correlation between insulin resistance and various mitochondrial characteristics [5,7]. However, there is
considerable conflict in the literature and whether alterations in skeletal muscle mitochondria are a
cause or consequence of insulin resistance is yet to be established [12].
The aim of this review is to present the evidence for and against a central role for mitochondria
in the development of insulin resistance. We will also discuss the potential role of altered substrate
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oxidation by the mitochondria as a contributor to insulin resistance. As exercise training is well
established as an effective intervention to improve a range of mitochondrial characteristics [13–15],
and beneficial in the treatment and prevention of T2D [16,17], we will also examine the link between
training-induced changes in mitochondrial characteristics and insulin resistance.
2. Mitochondria
Mitochondria are double-membrane organelles present in the majority of cells in the human body.
They are responsible for most cellular energy production via oxidative phosphorylation (OXPHOS).
In addition, they are involved in many essential cell functions related to homeostasis and
cellular metabolism, including intracellular calcium buffering and induction of apoptosis [18,19].
Mitochondria contain their own genome (mitochondrial DNA, mtDNA), which encodes 13 polypeptides
of the electron transport chain (ETC), as well as a number of transfer and ribosomal RNAs crucial to
mitochondrial function [20]. However, most of the mitochondrial proteome (~1600 proteins) is encoded
by the nuclear genome and both genomes are required for functioning mitochondria. Although often
represented as oblong independent organelles, skeletal muscle mitochondria form a large interconnected
network allowing for the sharing of components and removal of damaged components. The joining
and separating of mitochondria from the network is known as fusion and fission, respectively.
This is a highly dynamic process that helps mitochondria respond to cellular stresses [21]. In skeletal
muscle, mitochondria located just under the sarcolemma are called subsarcolemmal (SS) mitochondria,
while mitochondria located between the contractile filaments are referred to as intermyofibrillar (IMF)
mitochondria [22] (Figure 1). These two mitochondrial populations are believed to respond differently
to contraction and metabolism [23]. For example, while subsarcolemmal mitochondria make up just
10 to 15% of the mitochondrial pool, they are more likely to adapt to variations in muscle use [20].
Thus, the two mitochondrial populations may have unique relationships with insulin resistance [22].
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Figure 1. (A) Location of mitochondria within the skeletal muscle fibre. (B) Location of metabolic
processes within the mitochondria. Black boxes indicate a section of each figure that has been magnified
in the right-hand image. Created with BioRender.com.
Mitochondrial Terminology
There is considerable variability in the terminology used to describe mitochondrial characteristics,
as well as the techniques used to measure these characteristics. For example, despite its widespread use
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in the literature, there is currently no widely accepted definition of “mitochondrial biogenesis” [13,24,25]
and no consensus on how it is best measured. Given its etymological meaning, we have proposed to
define mitochondrial biogenesis as “the making of new components of the mitochondrial reticulum” [25].
It has been suggested that mitochondrial biogenesis can best be assessed by measuring the rate of
mitochondrial protein synthesis (mitoPS) [25,26], rather than measurement of changes in the expression
of genes and proteins. Nonetheless, while measurement of the synthesis rate of mitochondrial proteins
is indicative of mitochondrial biogenesis [25], a more comprehensive assessment of mitochondrial
content, structure, quality, and respiratory function, is required to interrogate the relationship between
changes in mitochondrial biology and insulin resistance [24,27].
Mitochondrial characteristics include content, size, cristae density, and function. In this review,
we will focus predominately on mitochondrial content and respiratory function, as these characteristics
have been more extensively investigated. Mitochondrial content refers to the overall volume or
density of mitochondria within a muscle or tissue. This can be measured directly using transmission
electron microscopy (TEM) or indirectly by measuring the activity of enzymes (e.g., citrate synthase),
cardiolipin content, or mtDNA content [28]. TEM can also be used to measure mitochondrial size
and cristae density. Mitochondrial respiratory function refers to the ability of mitochondria to use
oxygen to generate cellular energy. A search of the literature shows that this can be measured in a
variety of ways. This includes direct measures of mitochondrial respiration in isolated mitochondria or
permeabilised muscle fibres in vitro; this is commonly done by using either the Seahorse XF Analyzers
(Agilent) or Oroboros O2k (Oroboros Instruments). This can yield measures of mass- (per gram of
tissue for example) or mitochondrial- (per volume of mitochondria) specific respiration. Of direct
relevance to a number of studies cited in this review, respiratory function can also be measured in vivo.
A commonly used example is phosphorus magnetic resonance spectroscopy (31P MRS), which measures
the concentrations of phosphate metabolites and includes measures such as phosphocreatine and
ADP recovery time [29,30]. Other techniques used to describe or determine mitochondrial respiratory
function include in vitro assays, such as mitochondrial ATP production rate (MAPR); however, there is
some concern over whether the findings obtained with these in vitro techniques represent what would
occur in vivo [30].
In the literature, mitochondrial changes that are not considered favourable are often described
as ‘mitochondrial dysfunction’. However, this term has not been precisely defined and decreases in
mitochondrial respiratory function measured in permeabilised or isolated mitochondria in vitro or
via 31P MRS in vivo, as well as decreases in mitochondrial content, size, or density, or the activity
of individual enzymes, have all been used as evidence of ‘mitochondrial dysfunction’ [5,8,31–33].
The fact that mitochondria have many functions further highlights the lack of precision provided by
the term ‘mitochondrial dysfunction’. Other terms not consistently used between studies to describe
similar mitochondrial changes include ‘mitochondrial deficiency’, ‘mitochondrial derangements’,
and ‘decreased mitochondrial capacity’. This lack of a consensus, as well as the use of the term
‘mitochondrial dysfunction’ to describe a range of different mitochondrial changes, undoubtedly
contributes to confusion regarding the relationship between mitochondrial changes and various indices
of health. In this review, we have tried to avoid generic terms, such as ‘mitochondrial dysfunction’.
Instead, where possible, we have tried to refer only to the actual measurements made (e.g., changes in
mitochondrial content or respiratory function).
3. Insulin Resistance
Another area relevant to this review, where the terminology can be unclear, relates to the use of
the terms ‘insulin resistance’, ‘insulin sensitivity’, and ‘glucose/insulin (in) tolerance’. These terms,
like those associated with mitochondria, have arisen in part due to the use of different methods
and models. The gold standard for the measurement of insulin action in vivo is the hyperinsulinaemic
euglycaemic clamp. This technique involves the infusion of insulin at a steady rate to maintain
hyperinsulinaemia (sometimes a priming dose of insulin is used), which suppresses glucose output by
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the liver and encourages glucose uptake. Euglycaemia is maintained by a variable glucose infusion,
and this rate of glucose infusion indicates whole body insulin action. People or animals requiring
greater infusions of glucose are said to be insulin sensitive, while lower rates of glucose infusion are
required where insulin action is impaired, e.g., with insulin-resistant participants. When used in
conjunction with radioactive tracers, glucose uptake into peripheral tissues, such as skeletal muscle,
can also be determined [34]. However, a clamp can be invasive and not practical for some studies.
Thus, some studies have used calculations such as the homeostatic measure (HOMA) or the Matsuda
index, or similar calculations, which, at least in human populations, correlate well to clamp-based
measures of insulin sensitivity or resistance [35]. The use of these indices in rodents is not recommended,
as they do not appear to correlate as well [34]. Some studies also use measurements of glycated
haemoglobin (HbA1c) to give an estimate of blood glucose concentrations over an extended period.
Alternatively, oral and intraperitoneal (i.p.) glucose tolerance tests or i.p. insulin tolerance tests can be
used to provide measures of ‘glucose tolerance’ and ‘insulin tolerance’ respectively.
4. Mitochondrial Content and Insulin Resistance
A number of studies have found that non-diabetic obese people, and those with T2D, have a
decrease in mitochondrial content and size [5,7,36–40]. This has led to the hypothesis that decreased
skeletal muscle mitochondrial content is responsible for, or contributes to, the development of insulin
resistance [41,42]. If this were true, we would expect to consistently see a lower mitochondrial content
in patients with T2D. However, this is not always the case [32,43,44]. It may be that mitochondrial
content by itself does not directly influence insulin resistance, but instead may be indirectly involved
in some instances; this could be, for example, via alterations in reactive oxygen species (ROS) and/or
bioactive lipids. This will be discussed later in the review. In addition, a contributor to the contrasting
findings may be the different methods used to assess mitochondrial content and this is discussed first.
4.1. Methods of Mitochondrial Content Measurement
The gold standard for the measurement of mitochondrial content is TEM. However, citrate
synthase (CS) activity correlates well with TEM-derived measures of mitochondrial content [28],
is more readily measured in most laboratories, and is commonly used as an indirect marker of
mitochondrial content. Other commonly used measures of mitochondrial content, such as mtDNA
content, may be less reliable - at least in healthy individuals [28]. Some studies have instead examined
gene expression of mitochondrial proteins, particularly components of the ETC or proteins known to
be involved in mitochondrial biogenesis (e.g., PGC-1α). However, although these may give useful
information, expression of individual proteins or RNAs does not provide a valid assessment of
mitochondrial content [25]. Therefore, the different techniques used, as well as the reliability of these
measures, may explain some of the variability in findings as well as biological variation observed
within studied populations.
4.2. Mitochondrial Content in Patients With Insulin Resistance or Type 2 Diabetes
As alluded to earlier, the evidence indicating that skeletal muscle mitochondrial content is
lower in patients with insulin resistance and/or T2D is not conclusive; although many studies have
shown lower mitochondrial content, some have not (Table 1). Using CS activity as an indirect
marker, a lower mitochondrial content was detected in T2D, but not obese men [5], although this
value was normalised to creatine kinase activity and therefore difficult to compare to other studies.
However, there may be sex-specific differences as CS activity was observed to be lower in obese
women (insulin resistance not reported) when compared with lean women [37]. An alternative indirect
marker of mitochondrial content, mtDNA content, wasn’t different between diabetic and nondiabetic
subjects in one study [32] but was lower in T2D subjects compared with controls in another study [38].
It has also been reported that in contrast to long-term diagnosed T2D patients, mitochondrial content
was not significantly different in insulin-resistant (not T2D) participants when compared to BMI and
Int. J. Mol. Sci. 2020, 21, 6948 5 of 25
age-matched controls [39]. However, a study in Asian Indian participants found that despite displaying
a high level of insulin resistance these participants also had increased mitochondrial content [45].
Thus, although many studies have reported a lower mitochondrial content and/or size, this finding
is not consistent even when using the same method (e.g., TEM). From this data, it is also difficult to
determine whether a decrease in mitochondrial content precedes or follows the development of T2D
in humans.
Table 1. Mitochondrial content in patients with obesity and/or type 2 diabetes.
Study Population Method Finding
Chomentowski et al., 2011 [36] T2DNon-diabetic IR TEM
↓ IMF, no change SS
↓ IMF, no change SS
Ritov et al., 2005 [7] T2D TEM ↓ SS
Kelley et al., 2002 [5] ObeseT2D CS
No change
↓
Kim et al., 2000 [37] Obese CS ↓
Asmann et al., 2006 [32] T2D mtDNA No change
Boushel et al., 2007 [38] T2D mtDNA ↑
Nair et al., 2008 [45] T2D CS ↓
van Tienen et al., 2012 [39] T2DIR CS
↓
No change
Mogensen et al., 2007 [43] T2D CS No change
Holloway et al., 2007 [40] Obese CS ↓
Bruce et al., 2005 [44] Obese CS No change
Abbreviations: CS: citrate synthase activity; IMF: intermyofibrillar; IR: insulin resistant; mtDNA: mitochondrial
DNA; SS: subsarcolemmal; TEM: transmission electron microscopy; T2D: type 2 diabetes; ↓: lower, ↑: higher.
In addition to changes in overall mitochondrial content, alterations in mitochondrial distribution
may occur with type 2 diabetes. Thus, TEM has also been used to examine changes to specific
mitochondrial populations, but again without consistent results. In one study in non-diabetic,
insulin-resistant participants and T2D patients, both groups had lower IMF, but not SS, mitochondria
content relative to insulin-sensitive lean participants (~20% lower in insulin-resistant participants,
and ~40% lower in T2D patients) [36]. Another study reported lower SS mitochondrial content in
T2D patients in comparison to lean controls [7]. Yet, another study found no difference between the
content of SS and IMF mitochondria in T2D participants compared to controls [46]. Studies examining
mitochondrial size via TEM have also found either no change [36] or a decrease in mitochondrial
size in both obese and T2D participants [5]. Thus, it is unclear from studies in human participants
whether changes in mitochondrial size or distribution occur with insulin resistance. Other studies
have examined this relationship in animal models and this will be discussed later.
Studies in participants with a family history of T2D have attempted to determine whether a
decrease in mitochondrial content precedes T2D. In young men and women with a family history of
T2D, mitochondrial content (as measured by TEM) was decreased compared to controls [6]. In young
men with a family history of T2D, skeletal muscle mtDNA content was decreased in comparison to
men without a family history [47], suggesting the mitochondrial content changes occur prior to the
development of T2D. The results from these two studies indicate that a decrease in mitochondrial content
may precede the development of T2D. However, there could be other explanations for a decreased
mitochondrial content, including increased physical inactivity and obesity, as discussed below.
Int. J. Mol. Sci. 2020, 21, 6948 6 of 25
4.3. Correlations between Mitochondrial Content and Insulin Resistance
The potential link between lower mitochondrial content and insulin resistance has also been
examined by assessing the correlation between these two measures. Lower intermyofibrillar,
but not subsarcolemmal, mitochondrial content has been reported to be strongly correlated with
glucose disposal during a euglycaemic clamp in a group of participants that included individuals
who were lean insulin-sensitive, insulin-resistant, and or who had been diagnosed with type 2
diabetes [36]. Lower mitochondrial size has also been correlated with greater insulin resistance [5].
Furthermore, increases in skeletal muscle mitochondrial content (measured by cardiolipin content and
CS activity) have been reported to accompany improvements in hyperglycaemia in T2D patients [48].
However, Phielix et al. [9] found no relationship between mitochondrial content and insulin sensitivity;
in this study, mitochondrial content was measured by mtDNA content, which as noted above, has been
criticised as valid method to estimate mitochondrial content. Thus, studies in humans suggest that
mitochondrial content is correlated with insulin resistance, although this does not provide evidence of
a causative link between the two variables.
4.4. Interventions That Alter Mitochondrial Content and Their Effects on Insulin Resistance
Skeletal muscle mitochondrial content is known to be strongly influenced by physical activity,
with an increase in content with exercise training in both healthy individuals [13,49] and those with
insulin resistance [8,9,50–54]. In contrast, a decrease in mitochondrial content occurs following
manipulations that decrease physical activity, such as bed rest [55,56]. Thus, some researchers have
manipulated physical activity and investigated whether changes in mitochondrial content and insulin
resistance occur in parallel (Table 2).
In obese, but not diabetic, participants exercise training increases mitochondrial content as
assessed by increases in mtDNA content [9], the activity of ETC enzymes [52], CS activity [48,57,58],
and TEM [59,60], alongside improving measures of insulin resistance and glucose tolerance. In T2D
patients, exercise training can similarly improve insulin resistance and decrease hyperglycaemia [61]
while increasing mitochondrial content as measured by TEM [46] or surrogate measures (e.g., mtDNA,
CS activity) [9,61,62]. This would indicate exercise training increases mitochondrial content alongside
whole-body improvements in insulin resistance. In contrast, a study in sedentary T2D patients found
that although some measures of mitochondrial content were increased post-training, there was no
change in blood glucose concentration [50]. However, the lack of improvement in blood glucose in that
study may have been due to insufficient exercise frequency [16,17]. Exercise-induced improvements
in insulin resistance were recently shown to disappear after four non-exercise days [63], while other
studies have reported a much slower decline in mitochondrial content [49]. This suggests that
although exercise training is able to improve insulin resistance and increase muscle mitochondrial
content, exercise-induced improvements in insulin resistance may be related to acute effects rather than
longer-term changes such as alterations in mitochondrial content. This would support the hypothesis
that there isn’t a direct relationship between mitochondrial content and insulin resistance.
Conversely, weight loss, which is able to improve insulin sensitivity in insulin-resistant patients,
actually decreases mitochondrial size without changing mitochondrial content (measured by TEM) [60].
This led the authors to conclude that improvement of insulin sensitivity is not dependent on an increase
in mitochondrial content, but that changes in mitochondrial content are more likely linked to altered
physical activity levels [60]. Thus, in humans, skeletal muscle mitochondrial content does appear to
change alongside changes in insulin resistance (Figure 2). However, there is limited evidence for a
direct relationship between the two variables.
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interventions in individuals who are insulin resistant, obese, and/or have T2D.
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Bruce et al., 2006 [53] Male and female, obese,sedentary non-diabetic
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response less in SS
mitochondria
Abbreviations: β-HAD: beta-hydroxyacyl CoA dehydrogenase, CPT1: carnitine palmitoyltransferase 1, CS: citrate
synthase, COXIV: cytochrome c oxidase subunit 4, ETC: electron transport chain, HR: heart rate, HRmax: heart rate
maximum, HIIT: high intensity interval training, HOMA: homeostatic model assessment, HRR: high resolution
respirometry, H2O2: hydrogen peroxide, IMF: intermyofibrillar, MAPR: mitochondrial ATP production rate, MVC:
maximum voluntary contraction, ND: not determined, PCOS: polycystic ovary syndrome, PGC-1α: peroxisome
proliferator-activated receptor gamma co-activator 1-alpha, 31P MRS: magnetic resonance spectroscopy, QUICKI:
quantitative insulin sensitivity check index, RYGB: Roux-en-Y gastric bypass, SS: subsarcolemmal, TCA: tricarboxylic
acid, T2D: type 2 diabetes, VO2max: maximal oxygen uptake, Wmax: maximal work load.
4.5. Experimental Animal Models
As studies in human participants have not been able to confirm whether decreases in skeletal
muscle mitochondrial content cause insulin resistance, animal models have been used to investigate
the relationship between changes in insulin resistance and mitochondrial content. Animal studies can
more tightly control factors that can influence mitochondrial content such as physical activity, diet,
and body mass. Animal studies can also be used to manipulate mitochondrial content. For example,
overexpression of PGC-1α induces mitochondrial biogenesis and improves insulin-stimulated glucose
transport in lean and obese Zucker rats [70]. A recent study in Goto-Kakizaki (GK) rats examined various
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mitochondrial characteristics in comparison with control rats in response to hind-limb contraction.
GK rats have impaired β-cell insulin secretion and develop T2D at approximately three weeks of age.
This is followed by peripheral insulin resistance and hepatic glucose overproduction. GK rats are not
obese and are physically active. Despite developing T2D, this study found that there was no change
in mitochondrial content (measured by cytochrome c content) between the control and GK rats [71].
Zucker diabetic fatty (ZDF) rats, another model used to study insulin resistance, have increased number,
width, and content of subsarcolemmal mitochondrial compared to controls; however, intermyofibrillar
mitochondria are unchanged and CS activity is not different to controls [72]. In red muscle of Zucker
rats, intermyofibrillar mitochondria are larger in the obese animals compared to lean animals; however,
this size difference is not observed in the subsarcolemmal mitochondria nor in either mitochondrial
population in the white muscle. Mitochondrial content was increased in the red muscle of the obese
Zucker rats compared to lean animals [73]. Exercise training can further increase mitochondrial content
in these animals alongside improving hyperglycaemia, although insulin-mediated glucose uptake is
not improved [74]. Therefore, genetic animal models demonstrate that insulin resistance can occur in
the absence of changes in mitochondrial content.
Dietary models of insulin resistance (over nutrition or consumption of diets high in sucrose
or fat) are often used in rodent studies as they can more closely mirror the development of disease
in humans. In Wistar rats fed a high sugar diet, there are alterations of the mitochondrial ultrastructure
as well as an increase in CS activity [75]. Regular physical activity in these rats partially returned
mitochondrial ultrastructure towards the control values, although CS activity was not significantly
altered with exercise in the animals consuming a high sugar diet [75]. This suggests improvements
in mitochondrial content were not responsible for the improvements in glucose tolerance seen with
exercise training in these rats [75]. The feeding of a high fat diet (HFD) is a commonly used model of
the metabolic syndrome in rodents, as they develop insulin resistance, compromised β-cell function,
and greater total body and fat mass [76]. In rodents fed a HFD, contrasting findings have been reported
for markers of mitochondrial content, including mtDNA content, expression of OXPHOS proteins,
and CS activity, with some studies showing increased mitochondrial content [77–80], no change [81],
or a decrease in mitochondrial content [82]. These findings provide further evidence a decrease in
mitochondrial content per se is not responsible for insulin resistance, at least in rodent dietary models
of insulin resistance.
4.6. Conclusions
A lower skeletal muscle mitochondrial content has typically been observed in people with insulin
resistance and type 2 diabetes. However, there is not sufficient evidence from these studies, nor
those in animal models, to suggest this reduction in mitochondrial content has a causative role in the
development of insulin resistance. It has also been argued that the decrease seen is not sufficient to
cause insulin resistance, as skeletal muscle has enough mitochondria to allow for a large and sufficient
increase in substrate oxidation and ATP output during exercise [83,84]. Thus, lower skeletal muscle
mitochondrial content is not likely to be directly responsible for the development of insulin resistance
and T2D. Rather decreased mitochondrial content may occur in conjunction with other changes that
contribute to insulin resistance, such as an increase in bioactive lipids and ROS [85]. It has also been
proposed that some of the conflicting findings between animal models and humans may be associated
with the stage of diabetes development and circulating insulin concentrations [86]. However, although
total mitochondrial content is important, equally important is how well these mitochondria work;
i.e., their respiratory function.
5. Mitochondrial Respiratory Function
Mitochondria have many “functions”. In this section, we will focus on one of the most important
functions of mitochondria—to use oxygen to generate cellular energy. This is often measured via
maximum mitochondrial respiration (oximetry), but, as mentioned in the ‘mitochondrial terminology’
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section, this has also been measured using other techniques - some more representative than others.
As noted by Lewis et al. [87] and Holloszy [83], the many ways mitochondrial respiratory function has
been measured in the literature has likely contributed to some of the conflicting findings. For example,
use of different substrates or physiological or saturating ADP levels, or resting observations when
mitochondrial respiration is controlled by ATP demand [83,88], may have contributed to some of the
inconsistent findings.
A number of arguments have been made to counter the proposed central role of lower mitochondrial
respiratory function in the development of skeletal muscle insulin resistance. These arguments focus
on a number of factors, such as the large spare respiratory capacity in skeletal muscle (reviewed by
Holloszy [83,89]), the influence of the method of mitochondrial respiratory function measurement
(reviewed in Lewis et al. [87]), and studies in disease and knockout models in which mitochondrial
respiratory function is decreased but insulin resistance is absent [90,91]. In addition to measurement
differences, it has been suggested that mitochondrial respiratory function is not related to insulin
sensitivity, and that the joint observation of changes in mitochondrial content and/or respiration and
insulin resistance is coincidental or linked by a common factor (s), which might include physical
inactivity, obesity, or reduced skeletal muscle blood flow [92,93]. It has been further suggested that
a decrease in mitochondrial respiration is a consequence rather than a primary cause of the altered
cellular metabolism and insulin resistance that develops with nutritional overload [33,94,95].
5.1. Mitochondrial Respiratory Function in Patients with Insulin Resistance or Type 2 Diabetes
Previous studies have reported that insulin-resistant or T2D patient populations have lower
mitochondrial respiratory function [5,7,42,43,92,96–99]. For example, people with T2D have lower
mitochondrial respiratory function than controls, as measured by both 31P MRS [8] and high-resolution
respirometry in permeabilised muscle fibres [9]. However, other studies, using a variety of measurement
techniques, have either not found reductions in mitochondrial respiratory function or found
that observed decreases could be attributed to decreases in mitochondrial content [32,38,100,101].
Thus, although studies have observed that patients with T2D or even insulin resistance display lower
mitochondrial respiration, there are also studies with contradictory findings. Thus, it is not clear
whether mitochondrial respiration, independent of other contributing factors, particularly physical
activity, is lower in T2D or indeed responsible for the development of insulin resistance.
A potential cofounder contributing to the dissociation between mitochondrial function and insulin
resistance is the duration of T2D when the measurements are made [88]. One study observed a
decrease in mitochondrial respiration only in sedentary long-standing T2D patients, which suggests
that mitochondrial respiration does not precede or cause insulin resistance [39]. Several studies have
also examined the non-diabetic offspring of T2D parents. Petersen et al. [97] found that mitochondrial
respiratory function, as measured by 31P MRS, was decreased in insulin-resistant offspring [97],
although they did not control for mitochondrial content. However, skeletal muscle MAPR assessed
during a luciferase-based assay was not different between children of T2D mothers and controls [66].
Therefore, evidence of a decrease in mitochondrial function being an inherited defect leading to the
development of insulin resistance and T2D is inconsistent and requires further research.
5.2. Is There a Relationship between Mitochondrial Respiratory Function and Insulin Resistance?
Some studies have attempted to correlate mitochondrial respiration to insulin resistance. In a
study of control and T2D participants, no correlation was found between markers of insulin sensitivity
or insulin-stimulated glucose disposal and mitochondrial respiration [9]. In contrast, in non-diabetic
but insulin-resistant participants, mitochondrial respiration was correlated with insulin resistance.
However, after adjusting for physical activity and/or trunk fat mass, this relationship between muscle
insulin sensitivity and mitochondrial respiration was partially lost and no longer significant [98]. In a
study examining bed rest (an extreme form of physical inactivity), there was a positive correlation
between mitochondrial respiration and insulin sensitivity [55]. However, on further examination of
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these findings, this effect may have been due to changes in mitochondrial content rather than changes
in respiration [55]. Therefore, although some studies have observed parallel changes in mitochondrial
respiration and insulin resistance, the relationship between the two appears to be affected by other
factors, such as mitochondrial content, physical activity level, and fat mass.
5.3. Interventions That Alter Mitochondrial Respiration and Their Effects on Insulin Resistance
5.3.1. Physical Activity
Many T2D patients have a sedentary lifestyle. This has a negative impact on the physical capacity
of T2D patients, which is strongly associated with their disease status [102]. It has been demonstrated
in many studies of healthy individuals and those with insulin resistance and/or T2D that exercise
training can increase mitochondrial respiration [8,9,13–15,103] (Figure 3). Exercise interventions that
increase mitochondrial respiratory function have also been shown to improve insulin resistance [8,9].
Conversely, bed rest causes insulin resistance as well as reducing maximal and submaximal
mitochondrial respiration [56]. Although, when mitochondrial respiration was normalised to CS
activity these decreases were no longer statistically different [56]. Despite this, single leg immobilization
decreases respiration before any changes in the expression of components of the respiratory chain [104].
This suggests that changes in mitochondrial respiratory function may occur prior to changes in content,
which may take a longer time to occur. However, it is currently unclear whether improvements
in mitochondrial respiratory function are responsible for the concurrent improvements in insulin
resistance or if this occurs via different pathways. Further studies are required to fully answer
this question.
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Figure 3. (A) Fit, healthy individuals have increased mitochondrial respiratory function and are
insulin sensitive. (B) Patients with insulin resistance and type 2 diabetes (T2D) have comparatively
lower mitochondrial respiratory function and are insulin resistant. (C) Patients with insulin resistance
and T2D who are able to increase their physical activity see an improvement in mitochondrial respiratory
function and a reduction in insulin resistance. Glucometer represents the degree of insulin sensitivity,
and associated changes in blood glucose concentration. In panel (A), the glucometer shows blood
glucose in the normal range, and fit, healthy people have normal insulin sensitivity. In panel (B)
the glucometer shows the increased blood glucose concentrations present in people with insulin
resistance, which are improved with exercise training (panel C). Created with BioRender.com.
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5.3.2. Weight Loss
Weight loss plays an important role in the treatment of insulin resistance and type 2 diabetes [17].
Thus, studies have attempted to determine if significant weight loss in insulin-resistant and T2D
patients is accompanied by improvements in mitochondrial respiration. In obese women placed on a
very low-calorie diet, glucose metabolism was improved but mitochondrial respiration (measured
in permeabilised muscle fibres) was decreased [105]. In patients who had gastric bypass surgery
(which results in significant weight loss and improvements in insulin sensitivity), mitochondrial
respiration measured in permeabilised muscle using high-resolution respirometry was only improved
in the patients who also exercised [68]. This suggests a disconnect between improvements in insulin
sensitivity and skeletal muscle mitochondrial respiration, at least following weight loss.
5.4. Experimental Animal Models of Insulin Resistance and Mitochondrial Respiration
Factors such as physical activity levels and degree of obesity complicate investigations into the
relationship between mitochondrial respiratory function and insulin resistance. Some researchers
have therefore examined the relationship between mitochondrial respiration and insulin resistance
in experimental animal models that can more tightly control factors such as physical activity and
body mass.
Many studies in animal models with impaired mitochondrial respiratory function have found that
both basal and insulin-stimulated glucose transport are normal or increased [83,90,106]. For example,
a strain of skeletal-muscle-specific knockout mice with decreased ETC function have normal insulin
tolerance and increased glucose uptake via AMP kinase (AMPK) activation [90]. Reduced activity
of complex I of the ETC and decreased state-3 respiration in isolated mitochondria in skeletal
muscle homogenates has been reported following treatment with metformin and thiazolidinediones,
well known for improving insulin sensitivity [107]. In addition, there is increased mitochondrial
respiratory function in skeletal muscle from rats with streptozotocin-induced hyperglycaemia [106].
However, Petersen and Shulman [12] have suggested this could be explained by the upregulation
of other pathways (such as glycolysis or increased fat oxidation) to increase or maintain glucose
uptake [12]. Overexpression of heat shock protein (HSP) 72 in mouse skeletal muscle increases
mitochondrial oxidative capacity but decreases insulin resistance [108]. Thus, while some genetic
studies suggest a link between mitochondrial respiration and insulin resistance, the majority do not.
Dietary models have also been used to investigate the link between insulin resistance and
mitochondrial respiration. Rats and mice fed a HFD often have increased mitochondrial respiratory
function, despite showing insulin resistance and a reduction in glucose tolerance [77–79]. Another study
found no effects of a HFD on mitochondrial respiratory function when classical complex I and II
substrates were used [81]. However, the animals in this study only received the HFD for two weeks,
which may not have been sufficient to affect mitochondrial respiration. Measures of insulin resistance
were not undertaken. There are, however, studies using a HFD to induce insulin resistance in
mice that have reported a decrease in resting and insulin-stimulated soleus muscle mitochondrial
respiration [82] and decreased mitochondrial respiration and ADP sensitivity across a range of
biologically relevant ADP concentrations [31]. Despite this, rodents fed a high-fat, high-sucrose diet for
one month developed glucose intolerance (and diabetes after 16 weeks on this diet) but had no change
in mitochondrial respiration [33]. This suggests that decreases in mitochondrial respiration do not
precede the onset of diet-induced insulin resistance in mice. While there are some conflicting findings
in HFD rodents, these may be related to experimental factors such as differences in diet composition,
muscle studied, and method of mitochondrial respiration measurement (e.g., isolated mitochondrial
vs permeabilised muscle fibres). What is clear, however, is that diet-induced insulin resistance is not
always accompanied by a decrease in mitochondrial respiration and has often been associated with an
increase in mitochondrial respiration.
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5.5. Summary
In conclusion, many studies in humans have observed that mitochondrial respiratory function
is lower when insulin resistance is present. However, conflicting data from human participants,
and especially animal models, suggest that changes in insulin resistance can occur without
corresponding alterations in mitochondrial respiration and vice versa. Thus, there is not sufficient
evidence to conclude that a decrease in mitochondrial respiration is a direct cause of insulin resistance.
It is more likely that other another factor(s) link insulin resistance and mitochondrial respiration.
For example, it has been proposed that changes in mitochondrial β-oxidation lead to increases in
intracellular fatty acid metabolites, which disrupt insulin signalling [42]. Thus, in the next section
we will discuss the potential role of altered fatty acid oxidation and lipogenesis in insulin resistance.
An increase in ROS emission from the mitochondria has also been reported to contribute to insulin
resistance. However, discussion of this is beyond the scope of this review, and thus the reader is
directed to other relevant reviews for more information on this topic [109,110].
6. Fatty Acid Metabolism and Insulin Resistance
Intramyocellular lipid (IMCL) content is increased in people with obesity and T2D [42,92,95].
This could be due to increased fatty acid uptake by the muscle and/or decreased fatty acid oxidation
(FAO) in the mitochondria [37,42,111–113]. A mismatch between fatty acid uptake and oxidation can also
lead to the formation of a variety of fat-derived, potentially toxic, lipid metabolites, such as ceramides,
sphingomyelins, acylcarnitines, and diacylglycerols (DAG). These fatty acid metabolites have been
hypothesised to be involved in the development of insulin resistance, via impairment of insulin
signalling [12,113] and reduced insulin-stimulated glucose uptake by skeletal muscle [112,114,115].
While highly trained endurance athletes also have increased IMCL stores, they have normal insulin
sensitivity. This has been attributed to their increased ability to metabolise fat, which has been correlated
to their increased skeletal muscle mitochondrial content compared to controls [116]. This aligns with
the observation that exercise can prevent fatty acid induced insulin resistance through an increase
in fatty acid oxidation, as well as increased triglyceride (TG) synthesis and a reduction in bioactive
fatty acid metabolites such as DAG and ceramide species [117]. Thus, a mismatch between fatty acid
supply and oxidation by the mitochondria that leads to an increase in lipid metabolites may also be an
important determinant for skeletal muscle insulin resistance [12,42,113].
6.1. Increased Inter- and Intramyocellular Lipids in Patients with Obesity and Type 2 Diabetes
As noted above, patients with obesity, insulin resistance, or T2D have frequently been shown
to have greater IMCL stores. However, highly trained endurance athletes also have higher IMCL
compared to less active controls, but normal insulin sensitivity - a phenomenon referred to as the
“athlete’s paradox”. This has been explained by the ability of exercise training to improve lipid
turnover and lipid droplet (LD) quality and characteristics [118,119], and to increase FAO in the
mitochondria [8,50,53,120,121]. Endurance exercise training also promotes high rates of TG synthesis,
which alters intramuscular lipid portioning, localisation (by suppling FFA at the site of energy
demand), and lipotoxicity [119,122]. Consequently, it appears that endurance exercise training and
HFD differentially affect the quantity and composition of DAG molecular species in rat skeletal
muscle [123]. Thus, a simple increase in IMCL content cannot be responsible for skeletal muscle insulin
resistance; however, it may indicate a mismatch between lipid supply and oxidation.
While the greater IMCL stores per se do not appear to be an important determinant of insulin
resistance, the location of lipids within skeletal muscle may be important. Patients with T2D have
increased subsarcolemmal lipids, whilst lipids in the intermyofibrillar region are not different to
either obese controls or endurance-trained athletes. There is a strong inverse relationship between
subsarcolemmal lipid volume and insulin sensitivity, which is improved with exercise training [46].
The subcellular localisation of lipid species also appears to be important, with mitochondrial lipids
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having the ability to alter mitochondrial respiratory function and ROS production [94,124–126].
Perreault et al. [126] investigated the subcellular localisation of DAGs, ceramides, and sphingolipids
in the skeletal muscle of endurance athletes, lean participants, obese participants, and participants
with T2D. The mitochondrial/endoplasmic reticulum fraction had greater DAG species in lean participants
compared to T2D and in athletes compared to obese and T2D, and these were positively related to
insulin sensitivity. Within the same fraction, C18:0 ceramide content was related to insulin resistance.
However, when cytosolic lipids were examined there was no significant differences between groups and
no relationships between cytosolic lipids and insulin resistance. This gives an indication that while
overall lipids levels may not change, lipids specifically in the mitochondria [126], and the subcellular
localisation of lipids, which is not commonly measured, may be important factors when considering
the metabolic impact of increased skeletal muscle lipid content on insulin resistance.
6.2. Evidence for a Role of Impaired Mitochondrial Fatty Acid Metabolism in the Development of
Insulin Resistance
Studies in obese and/or T2D patients have often found defects in FAO as well as lower expression
and activity of enzymes important for FAO. For example, in obese women, palmitate oxidation and
β-HAD activity are lower compared with lean women [37]. In a study comparing sedentary, obese,
insulin-sensitive, and insulin-resistant women genes involved in lipid droplet and fatty acid metabolism
had lower expression in insulin-resistant compared with insulin-sensitive women. For example, gene
expression of carnitine palmitoyltransferase 1B (CPT1B), malonyl CoA decarboxylase, hormone
sensitive lipase, and adipose triglyceride lipase were lower in insulin-resistant women compared
to insulin-sensitive women [127]. The authors also reported that low oxidative capacity of skeletal
muscle was associated with ceramide accumulation and insulin resistance [127]. In contrast, studies
using isolated mitochondria from participants with obesity and T2D do not show reductions in FAO
rate [40,62]. However, it was noted in one of these studies that FAO was reduced at the whole-muscle
level [40]. This suggested that either reductions in mitochondrial content were responsible for the lower
FAO rate rather than intrinsic reductions in the ability of the mitochondria to metabolise fats, or that only
a small proportion of the mitochondrial pool was studied due to the mitochondrial isolation technique
used [40]. However, other studies have not found defects in mitochondrial content, respiratory function,
or ATP synthesis with acute periods of increased fatty acids [128,129]. Therefore, although there is
some evidence FAO is decreased in those with insulin resistance, these findings aren’t uniform and the
influence of reduced FAO on the development of insulin resistance is unclear. The connection between
reduced FAO and insulin resistance may involve multiple different pathways, including the possibility
that lipid-induced insulin resistance results from mechanisms that decrease glucose uptake but which
are not linked to an impairment in mitochondrial FAO.
In addition to lower rates of FAO, greater rates of incomplete FAO may also accompany insulin
resistance. High lipid availability can lead to high lipid transport into the mitochondrial matrix.
However, without greater metabolic ATP demand this can result in incomplete FAO that leads
to the accumulation of bioactive lipids such acylcarnitines. For example, it has been found that
patients with T2D have increased β-HAD activity but no increase in CS activity. This could lead
to a situation whereby there is increased production of acylcarnitines [130]. Higher levels of these
bioactive lipid metabolites may then interfere with insulin signalling, glucose uptake, and potentially
mitochondrial respiration [80,95,117,131,132]. It has been reported that patients with poorly controlled
T2D have greater incomplete FAO in comparison to those whose diabetes is well controlled, and this is
associated with higher insulin resistance and higher HbA1c. Furthermore, linear regression found
that incomplete FAO explained 40% of the variance in insulin resistance and 69% of the variance in
HbA1c levels [130]. Thus, it has been hypothesised that incomplete FAO may be a factor contributing
to insulin resistance [12].
Lending support to this hypothesis is that some studies have found that when mitochondrial
fatty acid entry is limited, such as by deleting or inhibiting CPT1b in skeletal muscle, there is a
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corresponding improvement in glucose homeostasis and lipid-induced insulin resistance [95,133,134].
Conversely, a separate study in rats overexpressing CPT1b found insulin action is increased and
is sufficient to prevent lipid-induced insulin resistance in skeletal muscle. This was accompanied
by a decrease in TG content, and the membrane to cytosolic ratio of DAG. However, markers of
mitochondrial content or function were not altered by overexpression of CPT1b nor were there any
changes to the skeletal muscle acylcarnitine profiles irrespective of diet [135]. In addition, obese
women have decreased CPT1 activity in comparison to lean controls [37]. The reasons for these
seemingly conflicting findings are unclear, but it has previously been suggested that this could be due
to methodological differences such as length of the HFD, muscles examined or manipulated, and/or
method of manipulating CPT1b levels [135]. However, despite these conflicting findings, collectively
the literature does suggest that changes in the entry of fatty acids into the mitochondria and changes to
FAO may influence glucose homeostasis.
6.3. The Influence of Exercise Training and Weight Loss on Imcl Stores and Fatty Acid Oxidation
Exercise training is a common manipulation that is known to improve FAO [117,136,137],
to decrease DAG and ceramide accumulation [53,138], and to alter lipid localisation in skeletal
muscle [126] alongside improvements in insulin resistance (also discussed above). In contrast, some
studies have not found a direct link between exercise-training-induced improvements in muscle lipids
and/or fatty acid oxidation and insulin resistance [62,139]. As dietary interventions and significant
weight loss are also known to improve insulin resistance, the impact of significant weight loss on IMCL
and FAO has been examined both together and independently of exercise training. A study comparing
the effects of weight loss and exercise separately in sedentary overweight or obese men found that
while insulin resistance, DAG content, body mass, and fat mass were improved by both interventions,
muscle TG and lipogenic enzyme content decreased with diet-induced weight loss whilst increasing
with exercise. Ceramide and sphingosine content only decreased with exercise training, and not with
weight loss only. However, changes in total DAG, ceramides, and sphingolipids did not correlate
with changes in glucose disposal [138]. A comparison between patients post gastric bypass surgery
found those who also undertook moderate-intensity exercise training saw greater decreases in skeletal
muscle ceramides and certain species of sphingolipids and a greater improvement in insulin sensitivity,
while TG were decreased to a similar extent [68]. Thus, the results of studies using exercise and diet
manipulations that alter IMCL stores, FAO, and lipid metabolites are yet to establish a clear relationship
between these factors and insulin resistance.
6.4. Evidence from Animal Models
A number of animal models have also been utilised to investigate the potential link between FAO
and insulin resistance. While HFD rodents develop insulin resistance, the skeletal muscle from HFD mice
has been reported to have an increased capacity for FAO, with either no difference in the ratio of complete
to incomplete FAO [79] or increased rates of incomplete FAO and greater accumulation of β-oxidation
intermediates [22]. HFD mice also have increased oxidative enzyme activity (β-HAD—β-hydroxyacyl
CoA dehydrogenase, MCAD—medium-chain acyl-CoA dehydrogenase, and CS) and protein expression
of PGC-1α, uncoupling protein (UCP)3, and mitochondrial respiratory chain subunits, as well as
the expression of enzymes and transporters involved in β-oxidation [79,81]. CPT1b, in particular,
is increased in the skeletal muscles of rodents fed a HFD [79,81]; this is most likely due to an increase in
mitochondrial biogenesis in these animals as CPT1b activity is not changed in isolated mitochondria [80].
This does not appear to be specific to rodents, as consumption of a western diet (containing increased
sucrose and fructose, as well as fats) by female cynomolgus macaques increases FAO in comparison to
macaques eating a Mediterranean diet [140]. Thus, results from various high fat diet animal models
indicate that insulin resistance can occur despite an increase in mitochondrial FAO.
Consistent with the above, previous trials to increase β-oxidation via pharmaceutical or genetic
means in mice fed a HFD have been insufficient to protect them from insulin resistance [94,141,142].
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In addition, other rodent models of diabetes show increases in FAO, but this does not seem sufficient
to protect them from diabetes. For example, rats treated with streptozotocin show increased lipid
transport/sensitivity alongside increased glucose concentrations, despite increased fat oxidation [143].
Leptin deficient ob/ob mice (a rodent model of type 2 diabetes) also have an increase in mitochondrial
proteins associated withβ-oxidation compared to lean controls [144]. This suggests that these mice have
an increased ability for FAO in skeletal muscle compared to lean controls [144]. Together these results
indicate that increases in β-oxidation without a corresponding increase in oxidative phosphorylation as
a result of increased ATP demand are not sufficient to protect against insulin resistance. Consistent with
human studies, the results from these animal studies have not established a strong link between
decreased FAO in the mitochondria and the development of insulin resistance.
6.5. Summary
A mismatch between fatty acid uptake and oxidation, which leads to an increase in IMCL content
and lipid metabolites, has been observed in individuals with insulin resistance and T2D [42,92,95].
However, the elevated IMCL content in highly trained endurance athletes, a phenomenon referred
to as the “athlete’s paradox”, argues against the hypothesis that an increase in IMCL per se is an
important determinant of skeletal muscle insulin resistance. However, the subcellular localisation
may be an important factor when considering the metabolic impact of increased skeletal muscle lipid
content on insulin resistance. Even if total IMCL content is not a direct cause of insulin resistance,
it may be an indicator of a potential mismatch between fatty acid supply and oxidation, which,
if also associated with an increase in lipid metabolites, may contribute to the development of insulin
resistance. The accumulation of lipid metabolites may also explain the observation of reduced fatty
acid oxidation, or greater rates of incomplete fatty acid oxidation, in the mitochondria with insulin
resistance. However, there are many conflicting findings and more research is required to establish the
contribution of changes in fatty acid uptake, fatty acid oxidation in the mitochondria, IMCL content,
and lipid metabolites in the development of insulin resistance.
7. Conclusions
There is substantial evidence that people who have type 2 diabetes or insulin resistance have
reduced skeletal muscle mitochondrial content and respiratory function. Furthermore, both insulin
resistance and mitochondrial characteristics can be improved by exercise training. However, despite
this seemingly correlative relationship there is insufficient evidence to suggest that mitochondrial
content and respiratory function directly affect insulin sensitivity. Instead, there is stronger evidence
that insulin resistance may be due to the increase in lipid metabolites that occurs when an increase in
the supply of fatty acids is not matched by a commensurate increase in IMCL synthesis and fatty acid
oxidation in the mitochondria (which has been associated with mitochondrial content). Future studies
investigating the influence of manipulating mitochondrial content, mitochondrial respiratory function,
IMCL content, lipid metabolites, and fatty acid oxidation on insulin resistance may prove useful to
untangle to complex relationship between mitochondria and insulin resistance.
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Abbreviations
B-HAD Beta-hydroxyacyl CoA dehydrogenase
BMI Body mass index
CPT1 Carnitine palmitoyltransferase
CS Citrate synthase
CI-CV Complexes I–V of the electron transport chain
DAG Diacylglycerol
ETC Electron transport chain
FAO Fatty acid oxidation
GK Goto-Kakizaki (rats)
HbA1c Glycated haemoglobin
HFD High fat diet
HOMA Homeostatic model assessment




MAPR Mitochondrial ATP production rate
mtDNA Mitochondrial DNA
OXPHOS Oxidative phosphorylation
PGC-1α Peroxisome proliferator-activated receptor gamma co-activator 1alpha
31P MRS Phosphorus magnetic resonance spectroscopy
ROS Reactive oxygen species
SS Subsarcolemmal
TCA Tricarboxylic acid
TEM Transmission electron microscopy
TG Triglyceride
T2D Type 2 diabetes
UCP3 Uncoupling protein 3
ZDF Zucker diabetic fatty (rat)
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